Thomas S Guillot
Overview
Explore the profile of Thomas S Guillot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1044
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caudle W, Richardson J, Delea K, Guillot T, Wang M, Pennell K, et al.
Toxicol Sci
. 2022 Jan;
186(1):175.
PMID: 35079840
No abstract available.
2.
Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice
Stout K, Dunn A, Lohr K, Alter S, Cliburn R, Guillot T, et al.
ACS Chem Neurosci
. 2016 Aug;
7(10):1364-1373.
PMID: 27501345
Drugs of abuse induce sensitization, which is defined as enhanced response to additional drug following a period of withdrawal. Sensitization occurs in both humans and animal models of drug reinforcement...
3.
Alter S, Stout K, Lohr K, Taylor T, Shepherd K, Wang M, et al.
Exp Neurol
. 2015 Oct;
275 Pt 1:17-24.
PMID: 26428905
We previously demonstrated that mice with reduced expression of the vesicular monoamine transporter 2 (VMAT2 LO) undergo age-related degeneration of the catecholamine-producing neurons of the substantia nigra pars compacta and...
4.
Lohr K, Stout K, Dunn A, Wang M, Salahpour A, Guillot T, et al.
ACS Chem Neurosci
. 2015 Mar;
6(5):790-9.
PMID: 25746685
The psychostimulant methamphetamine (METH) is highly addictive and neurotoxic to dopamine terminals. METH toxicity has been suggested to be due to the release and accumulation of dopamine in the cytosol...
5.
Lohr K, Bernstein A, Stout K, Dunn A, Lazo C, Alter S, et al.
Proc Natl Acad Sci U S A
. 2014 Jul;
111(27):9977-82.
PMID: 24979780
Disruption of neurotransmitter vesicle dynamics (transport, capacity, release) has been implicated in a variety of neurodegenerative and neuropsychiatric conditions. Here, we report a novel mouse model of enhanced vesicular function...
6.
Caudle W, Guillot T, Lazo C, Miller G
Neurotoxicology
. 2012 Jul;
33(3):585.
PMID: 22774228
No abstract available.
7.
Kile B, Walsh P, McElligott Z, Bucher E, Guillot T, Salahpour A, et al.
ACS Chem Neurosci
. 2012 Jun;
3(4):285-292.
PMID: 22708011
Electrochemical detection with carbon-fiber microelectrodes has become an established method to monitor directly the release of dopamine from neurons and its uptake by the dopamine transporter. With constant potential amperometry...
8.
Caudle W, Guillot T, Lazo C, Miller G
Neurotoxicology
. 2012 Feb;
33(2):178-88.
PMID: 22309908
The exposure of the human population to environmental contaminants is recognized as a significant contributing factor for the development of Parkinson's disease (PD) and other forms of parkinsonism. While pesticides...
9.
Hashemi P, Walsh P, Guillot T, Gras-Najjar J, Takmakov P, Crews F, et al.
ACS Chem Neurosci
. 2011 Nov;
2(11):658-666.
PMID: 22125666
Fast-scan cyclic voltammetry (FSCV) at carbon fiber microelectrodes can be used to measure behaviorally correlated dopamine changes in the extracellular fluid of the brain of freely moving rats. These experiments...
10.
Street S, Walsh P, Sowa N, Taylor-Blake B, Guillot T, Vihko P, et al.
Mol Pain
. 2011 Oct;
7:80.
PMID: 22011440
Background: Prostatic acid phosphatase (PAP) and ecto-5'-nucleotidase (NT5E, CD73) produce extracellular adenosine from the nucleotide AMP in spinal nociceptive (pain-sensing) circuits; however, it is currently unknown if these are the...